Cover Image
Market Research Report
Product code 
1001527

South and Central America Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type, Product, Application

Published: | The Insight Partners | 93 Pages | Delivery time: 1-2 business days

Price

Back to Top
South and Central America Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type, Product, Application
Published: March 17, 2021
The Insight Partners
Content info: 93 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The South and Central America cell line development market is expected to reach US$ 728.17million by 2027 from US$ 304.25 million in 2019; it is estimated to grow at a CAGR of 11.7% from 2020 to 2027.

The market growth is attributed to factors such as growing government initiatives supporting cell line development projects and surge in cancer cases across South and Central America. However, the market growth is likely to be hindered owing to the several challenges regarding cell line development.

Cancer is among the leading causes of death across the globe and is profoundly affecting the quality of life. Lifestyle changes have resulted in greater exposure to oncogenic factors. Thus, cancer would be a burden on society if not diagnosed and treated on time. According to data from the article Revista Brasileira de Cancerologia 2018, there would be ~600,000 new cases of cancer during 2018-2019. The rising prevalence of cancer is escalating the demand for faster and effective therapeutics, which is boosting cell lines development activities. According to the World Health Organization (WHO), in 2018, ~129,047 new cancer cases were diagnosed in this region. Of these, 21,558 were breast cancer cases, while 7,165 were colorectal cancer cases, among others. Moreover, 15 people are diagnosed with cancer every 60 minutes in the country. In Argentina, various cancer types lead to ~68,000 mortalities per year, which is the third-highest cancer-led mortality rate in Latin America. Breast cancer is the most common type of cancer in this country, with 73 cases reported per 100,000 women each year. Cancer can be cured if diagnosed and treated at an initial stage. Next-generation sequencing (NGS) methods provide more information on the cancer-causing genes. Additionally, cell line-based studies aids in the research, diagnostics, and treatment of cancer.

Although a majority of clinical trials occur in high-income countries in South and Central America, the number of trials is increasing in developing countries as well, with major centers in Brazil. However, the pandemic has affected the research and development activities in these countries. Apart from this, a vast population already faces a growing burden of non-communicable diseases, making them more vulnerable to the virus. Further, economic uncertainties and ongoing conflicts are worsening the condition in the region. These factors are estimated to negatively impact the growth of the cell line development market in the region in the coming years. Also, sudden drop in domestic and external demand for goods and products and halted production due to labor shortage experienced as a consequence of the measures imposed to contain the COVID-19 spread. Additionally, tightened financial conditions is also decreasing the overall economic activities in the region.

Based on type, the South and Central America cell line development market is segmented into a primary cell lines, hybridomas, continuous cell lines, and recombinant cell lines. The recombinant cell lines segment held the largest market share in 2019, whereas the hybridomas segment is anticipated to register the highest CAGR in the market during the forecast period.

The South and Central America cell line development market, by product, is segmented into equipment, and media & reagent. The media & reagent segment held a larger share of the market in 2019, and it is further anticipated to register a higher CAGR in the market from 2020 to 2027.

Based on application, the South and Central America cell line development market is segmented into drug discovery, bioproduction, and tissue engineering. The bioproduction segment held the largest market share in 2019. However, the drug discovery segment is estimated to register the highest CAGR in the market during 2020-2027.

A few of the primary and secondary sources referred to while preparing the report on the South and Central America cell line development market are the Brazilian Association of Cell Therapy (ABTCel) and International Association for Stem Cell Application (ISSCA), Argentina.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South and Central America cell line development market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the South and Central America cell line development market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth, offering developed and emerging markets.

Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table of Contents
Product Code: TIPRE00020318

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Cell line development Market - By Type
    • 1.3.2 Cell line development Market - By Product
    • 1.3.3 Cell line development Market - By Application
    • 1.3.4 South and Central America Cell line development Market - By Country

2. South and Central America Cell Line Development Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South and Central America Cell Line Development Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Cell Line Development Market- South and Central America PEST Analysis
  • 4.3 Expert Opinion

5. South and Central America Cell Line Development Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Government Initiatives in the Cell Line Development Market
    • 5.1.2 An Upsurge in the Cancer Cases across South and Central America
  • 5.2 Market Restraints
    • 5.2.1 Several Challenges Regarding Cell Line Development
  • 5.3 Market Opportunity
    • 5.3.1 High Progress in the Pharmaceutical and Biotechnology Sector
  • 5.4 Future Trend
    • 5.4.1 Development of Innovative Strategies and Collaborations in the Cell Line Development Market
  • 5.5 Impact Analysis

6. Cell Line Development Market - South and Central America Analysis

  • 6.1 South and Central America Cell Line Development Market Revenue Forecasts and Analysis

7. South and Central America Cell Line Development Market Analysis and Forecasts To 2027 - By Type

  • 7.1 Overview
  • 7.2 Cell Line Development Market, by Type, 2019& 2027 (% Share)
  • 7.3 Primary Cell Line
    • 7.3.1 Overview
    • 7.3.2 Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.4 Hybridomas
    • 7.4.1 Overview
    • 7.4.2 Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.5 Continuous Cell Lines
    • 7.5.1 Overview
    • 7.5.2 Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.6 Recombinant Cell Line
    • 7.6.1 Overview
    • 7.6.2 Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)

8. South and Central America Cell Line Development Market Analysis and Forecasts To 2027 - By Product

  • 8.1 Overview
  • 8.2 Cell Line Development Market, by Product, 2019& 2027 (% Share)
  • 8.3 Equipment
    • 8.3.1 Overview
    • 8.3.2 Equipment Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.4 Media and Reagent
    • 8.4.1 Overview
    • 8.4.2 Media and Reagent Market Revenue and Forecast to 2027 (US$ Mn)

9. South and Central America Cell Line Development Market Analysis - By Application

  • 9.1 Overview
  • 9.2 Cell Line Development Market Share by Application 2019& 2027 (%)
  • 9.3 Drug Discovery
    • 9.3.1 Overview
    • 9.3.2 Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.4 Bioproduction
    • 9.4.1 Overview
    • 9.4.2 Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.5 Tissue Engineering
    • 9.5.1 Overview
    • 9.5.2 Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)

10. Cell Line Development Market Revenue and Forecasts To 2027 - Geographical Analysis

  • 10.1 South and Central America Cell Line Development Market, Revenue and Forecast to 2027
    • 10.1.1 Overview
    • 10.1.2 South and Central America Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
    • 10.1.3 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
    • 10.1.4 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
    • 10.1.5 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.1.6 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
    • 10.1.7 Brazil
      • 10.1.7.1 Brazil Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.1.7.2 Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.1.7.3 Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.1.7.4 Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.1.8 Argentina
      • 10.1.8.1 Argentina Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.1.8.2 Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.1.8.3 Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.1.8.4 Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)

11. Impact of COVID-19 Pandemic on South and Central America Cell Line Development Market

  • 11.1 South and Central America: Impact Assessment of COVID-19 Pandemic

12. COMPANY PROFILES

  • 12.1 Merck KGaA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Financial Overview
    • 12.1.4 Product Portfolio
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 General Electric
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Financial Overview
    • 12.2.4 Product Portfolio
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Lonza
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Financial Information
    • 12.3.4 Product Portfolio
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of terms

List Of Tables

  • Table 1. South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 2. South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 3. South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 4. Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 5. Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 6. Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 7. Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 8. Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 9. Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 10. Glossary of Terms, Cell Line Development Market

List Of Figures

  • Figure 1. Cell Line Development Market Segmentation
  • Figure 2. South and Central America Cell Line Development Market Overview
  • Figure 3. Bioproduction Segment Held Largest Share of Application in Cell Line Development Market
  • Figure 4. Brazil is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 5. Cell Line Development Market - South and Central America PEST Analysis
  • Figure 6. Cell Line Development Market Impact Analysis of Driver and Restraints
  • Figure 7. South and Central America Cell Line Development Market - Revenue Forecasts and Analysis - 2019- 2027
  • Figure 8. Cell Line Development Market, Type, 2019& 2027 (% Share)
  • Figure 9. Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 10. Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 11. Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 12. Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 13. Cell Line Development Market, By Product, 2019& 2027 (% Share)
  • Figure 14. Equipment Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 15. Media and Reagent Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 16. Cell Line Development Market Share by Application 2019& 2027 (%)
  • Figure 17. Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 18. Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 19. Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 20. South and Central America Cell Line Development Market, Revenue Overview, By Country, 2019 (US$ Mn)
  • Figure 21. South and Central America Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 22. South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
  • Figure 23. Brazil Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 24. Argentina Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 25. Impact of COVID-19 Pandemic in South and Central America Country Markets